Anne Li 1/29/17 NCI recently released The Economics of Tobacco and Tobacco Control, the latest in a series of monographs on tobacco use and tobacco control. Produced in collaboration with the World Health Organization, the…...
Anne Li 1/29/17 The National Cancer Institute (NCI) today launched a new drug formulary (the “NCI Formulary”) that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in…...
Anne Li 1/29/17 A study, partly funded by Worldwide Cancer Research, reveals for the first time that the protein CPEB4 can prevent fatty liver disease. The results were published today in Nature Cell Biology. A team co-led by two Worldwide…...
Anne Li 1/15/17 Estrogen is an important female hormone that signals the breasts to form during puberty. It's a necessity for normal mammary gland development. Yet, in some cases, the hormone also…...
Anne Li 1/15/17 The type of cancer a person has – and how it gets treated – is no longer just about where in the body the cancer started, such as in the breast…...
Anne Li 1/15/17 New research published by Worldwide Cancer Research scientist Professor Adrian Whitehouse and his team points to a potential new way to prevent the rare cancer Kaposi’s sarcoma. Their work is published in…...
Anne Li 1/15/17 This week the drug olaparib (also known as Lynparza) was approved for use in Scotland for women with ovarian cancer by the Scottish Medicine’s Consortium. Scottish charity Worldwide Cancer Research funded work which…...
Anne LI 1/15/17 A study partly funded by UK charity Worldwide Cancer Research and headed by Professor Salvador Aznar Benitah, at the Institute for Research in Barcelona (IRB) have identified for the first time a specific…...
Anne Li 1/15/17 A drug most commonly used to treat depression may also reduce joint pain in some women being treated for early-stage breast cancer, according to the results of a randomized clinical…...
Anne Li 1/15/17 The National Cancer Institute (NCI) today launched a new drug formulary (the “NCI Formulary”) that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical…...